Since livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) was detected in pigs in the Netherlands [1], research on MRSA in animals has increased enormously and is far from being complete. Indeed, new findings create new questions regarding how LA-MRSA is evolving. Although it began as a single clonal complex (CC) 398 most of which was sequence type (ST) 398, it is clear now that its diversity is much greater and is rapidly changing over time [2•]. The number of staphylococcal protein A gene (spa) types within CC398 is nowadays increasing [2•]. Furthermore, other S. aureus lineages among animals have acquired methicillin resistance [3]. Moreover, it is obvious that the spread of MRSA in livestock differs geographically, with CC398 being the most prevalent CC in Europe and USA and CC9 predominating in LA-MRSA cases in Asia. Clearly, in Asia LA-MRSA is evolving differently.

Still unanswered is the question, “From where, seemingly all of a sudden, does this methicillin resistance emerge?” Studies have shown that after a host jump of CC398, which was a human-associated clone, to animals, it acquired the staphylococcal cassette chromosome (SCC) mec (SCC) mec [4••]. However, few reports were published regarding the presence of methicillin resistance in staphylococci, and reports on the presence of a methicillin resistance reservoir in staphylococci other than S. aureus were rare. Recently, though, several studies found a high prevalence of methicillin resistance in staphylococci other than S. aureus [59, 10••, 11]. Nevertheless, it remains to be determined whether this may be the origin of the SCCmec in livestock-associated S. aureus. Clearly, more research is needed in this field.

Besides its presence in livestock animals, methicillin resistance is being reported more frequently in pet animals (cats and dogs) as well, and this resistance seems to be increasing [12, 13]. The epidemiology in pets, however, appears to be quite different and is limited to some Staphylococcus pseudintermedius and human-derived clones as well as in methicillin-susceptible S. aureus (MSSA) of CC398 [14]. LA-MRSA has been found only in pets residing on farms [13]; therefore, this review will not discuss pet animals.

In this article, we review the current situation regarding LA-MRSA and methicillin resistance in other staphylococci to assess whether the methicillin resistance in S. aureus might originate from other resident staphylococci. After a general description of LA-MRSA, we first provide an overview of the current situation regarding LA-MRSA in different parts in the world and the evolution of this bacterium. Then, we discuss the potential transfer of methicillin resistance from other staphylococci of animal origin to new S. aureus clones.

General Characteristics of LA-MRSA

The first description of LA-MRSA, formerly known as non-typeable (NT) MRSA, included the non-typeability of the strain based on standard pulsed field gel electrophoresis (PFGE) using the restriction enzyme SmaI [1] and was limited to ST398 isolates. Since then, much evolution has occurred, and more sequence types are included now [15, 16]. Although CC398 is still the most common LA-MRSA worldwide, its prevalence differs geographically; in certain regions, other sequence types are involved, such as ST9 in Asia. In addition, the diversity among sequence types is greater in some areas than in others, although the reasons for this remain unclear. In this part, we focus on the most prevalent sequence types found.


CC398 LA-MRSA is the major clonal complex found in Europe and North America. It occasionally is observed in Asia [17] and also has been detected in Africa [18, 19]. This complex is associated mainly with the colonization of pigs and veal calves [2•, 20, 21••, 22, 23••, 24, 25]. CC398 isolates also have been detected infrequently in poultry [26] and horses [27, 28]. Whole-genome sequencing has shown that this clone originated in humans [4••]; indeed, in humans, CC398 still occurs mainly as MSSA [15, 29•, 30, 31], albeit at a low prevalence. MSSA CC398 also remains present in animals, including pigs [32], dogs [14], bovines [29•], and poultry [29•, 33••]. Currently, CC398 includes 43 sequence types [34], but the major MRSA sequence type colonizing pigs is ST398. Other STs described in pigs are ST541, ST1965, ST1966, ST1967, and ST1968 [16, 35, 36]. However, it has been shown that there is a specific subgroup of human ST398 strains, different from LA-MRSA ST398 [37], that can be readily differentiated by SNP detection and the presence or absence of scn and tet(M) [38]. Research in the Netherlands revealed that all the CC398 strains there typically are LA-MRSA [39]. Nevertheless, the prevalence of MSSA CC398 infections and colonization seems to be increasing, albeit with major geographic differences [4042].

LA-MRSA CC398 is not considered to be very pathogenic in humans. In animals, however, it has been implicated in bovine mastitis [23••, 4346] and in infected foot joints in turkeys [33••]. Little information is available regarding pigs because Staphylococcus hyicus is the major pathogenic Staphylococcus species in these animals [47], although S. aureus has been isolated occasionally from lesions in pigs [47]. More recent reports, however, show that LA-MRSA CC398 may infect humans and pigs more often than previously thought [4850], but this question needs further study.

Typical of this clone is its multiresistance to several classes of antimicrobial agents. In LA-MRSA CC398 strains, typical S. aureus resistance genes have been detected against trimethoprim [dfrA (dfrS1), dfrD, dfrG], tetracycline [tet(K), tet(M), tet(L)], macrolides [msr(A)], lincosamides [lnu(A)], macrolide–lincosamide–streptogramin B [erm(A), erm(B), erm(C)], pleuromutilin–lincosamide–streptogramin A [vga(A)], phenicols (fexA), aminoglycosides (aacA-aphD, aadD, aphA3, spc), and mupirocin (mupA) [5153]. New resistance genes also have been found frequently in this clone, such as those against aminoglycosides (apmA, spd), trimethoprim (dfrK), macrolide–lincosamide–streptogramin B [erm(T)], and pleuromutilin–lincosamide–streptogramin A [vga(C), vga(E), lsa(E)] [51, 52, 54, 55]. This clone also can easily acquire more rare genes, such as the multiresistance gene cfr (encoding resistance to “PHLOPSA” antibiotics: phenicols, lincosamides, oxazolidines, pleuromutilins, and streptogramins), first found in Staphylococcus sciuri and later in other staphylococci as well as in other genera, including Gram-negative bacteria, which is of great importance given the diversity of antibiotics to which this gene is encoding resistance [56].

The two predominant SCCmec types among CC398 isolates are SCCmec IVa and V; however, IV variants such as SCCmec type IV (2B&5), as well as III and NT types, have been described in bovines [22, 29•] and pigs [2•]. The CC398 isolates firstly identified as carrying SCCmec type III, via the SCCmec PCR typing scheme developed by Zhang et al. [57] corresponded in fact to isolates carrying SCCmec type V [58, 59]. However, LA-MRSA CC398 harboring SCCmec type III was described in bovines [22] and pigs [2•] by researchers using a SCCmec PCR typing scheme developed by Kondo et al. [60].

The ability of MRSA CC398 to acquire foreign DNA may be one of its most dangerous features. It is capable of acquiring virulence genes, and its acquisition of the Panton–Valentine leukocidin (PVL) gene (pvl) has been demonstrated [37, 61, 62]. Regarding other virulence factors, staphylococcal enterotoxins occasionally have been reported in LA-MRSA CC398 in pigs [53, 6365] and turkeys [33••]. In contrast, genes encoding adhesion factors, proteases, hemolysins, other leukocidins, and superantigen-like proteins have been detected frequently in LA-MRSA CC398 isolates from pigs [2•], poultry [26, 33••], and bovines [22]. CC398 strains of human origin carry genes of the immune evasion cluster (IEC), whereas these genes usually were absent in CC398 isolates from animals [66]. However, IEC genes were detected among isolates recovered from nosocomial infections in horses, as well as in veterinarians [66]. In contrast to most other S. aureus clones, LA-MRSA CC398 shows little host specificity; therefore, it can move easily between hosts and acquire genes. Once this strain becomes more virulent, it may become a very dangerous pathogen for various animal species, including humans.

Although when MRSA CC398 was first discovered there were few sequence types and spa types involved, these seem to be increasing over time, as was shown recently in Belgium for the different spa types involved in colonizing pigs [2•]. This observation implies that the CC398 population is still evolving quite rapidly. However, this variability differs among countries, as shown in the European Food Safety Authority (EFSA) surveillance of 2008 [67]. In addition, in some countries, different spa types may constitute most of the isolates, possibly indicating the local circulation of certain strains. Many experts assume that a regionally high variability is related to the international trade of pigs and that countries with high trade levels have a greater diversity of strains [36, 67, 68].


CC9 is the major LA-MRSA clone found in Asia, although its prevalence may vary substantially among Asian countries [17]. The first time an ST9 strain was found in Europe was in 2008, in Italy, although the most prevalent ST was the typical European ST398 [3]. Since then, LA-MRSA ST9 isolates have been detected in pigs [48] and poultry [69] from Germany and in retail meat from the UK [70]. However, a recent study shows that LA-MRSA ST9 was present in some European countries before the emergence of CC398 [71].

This sequence type also is found as MSSA in pigs [72]. It was one of the most frequent STs in a study in Minnesota in the USA [73] and was identified as one of the most common MSSA strain in pigs in a study comparing it with a historic collection of MSSA strains [71]. Although the reasons for the differences seen between Asia and the rest of the world remain obscure, it is quite possible that SCCmec was acquired only by Asian strains and not by the European ones. ST9 MRSA has been studied much less extensively than CC398 MRSA; however, in contrast to CC398, it is a typical swine-associated sequence type, although it occasionally may be found infecting humans [7476]. MRSA ST9 isolates also have been shown to be animal pathogens, as they have been implicated in mastitis in bovines [77].

Similar to CC398 MRSA, the CC9 strains are generally multiresistant, and besides the typical resistance genes, they also carry rare resistance genes against lincosamides [lnu(B)], pleuromutilin–lincosamide–streptogramin A [lsa(E)], and PHLOPSA (cfr) [52, 56]. Several SCCmec types have been found in CC9 strains, including SCCmec III, IV, and V and novel and NT types [17]. This large variety of SCCmec types indicates the high number of acquisitions in these strains, whereas in ST398, the types are mainly IV and V as well as occasional NT SCCmec elements.

Some virulence genes have been found in MRSA ST9, including pig strains with PVL [78]. Studies from several Asian countries and Germany found that more than 90 % of LA-MRSA ST9 isolates carried at least one enterotoxin gene [17]. Moreover, a high detection rate of the toxic shock syndrome toxin (TSST-1) gene (tst), but a negative expression of the TSST-1 phenotype, also was reported in LA-MRSA ST9 isolates [76].

The CC9 isolates show a great variety of spa types with a certain geographic distribution. According to Espinosa-Gongora et al. [71], the first European CC9 isolates were discovered between 1973 and 2009 and carried diverse spa types (t337, t526, t899, t1334, t2498, t3446). The European isolates found recently carry mainly spa types t337 [48], t1430 [48, 69], t1939 [70], and t4794 [3]. CC9 Asian isolates carry diverse spa types, such as t899, t4358, and t337 [17].


The CC97 clonal complex has undergone quite an evolution. It is a leading cause of bovine mastitis worldwide [43, 77, 79, 80] and is found occasionally in small ruminants, pigs, and humans. It was determined that the human strains originated from a bovine to human host jump believed to have occurred approximately 40 years ago and subsequently acquired methicillin resistance [81]. MSSA CC97 strains are still circulating in humans [82, 83].

This clonal complex has been associated with pigs for quite some time and is found in historic collections dating back to the 1970s as well as in current collections [71]. MRSA ST97 was first discovered in Italy in pigs [3]. Later, CC97 was found in Spain, being the first isolate of a new single locus variant of ST97, namely, ST1379 [84]. In that study, CC97 represented nearly 10 % of the strains, with the remaining being ST398 isolates [84]. Subsequently, CC97 was also found among pigs in Spain [82] and in humans [85, 86].


MRSA strains of CC1 belong to a very successful human lineage of community-acquired (CA) MRSA. CC1/ST1 is one of the major clones circulating in Italy, where it first was reported in pigs [87, 88] and dairy cows [43], and seems to be spreading to other countries. In 2009, one strain was detected in Denmark [89], and recently a few strains were discovered in veal calves and pigs in Belgium [29•]. In humans, strains of this CC tend to carry the PVL toxin. Fortunately, to date and to our knowledge, PVL-positive MRSA CC1 isolates have not yet been isolated from animals; however, typically present are the IEC genes sak and scn, or the enterotoxine gene sea as in human strains, and they also may carry β-hemolysins, LukF–LukS, LukD–LukE, LukX–LukY γ-hemolysin, enterotoxin H, and superantigen X [87, 90]. The typical strain found in animals belongs to spa type t127 [43, 8789]. MRSA CC1 also has been implicated in mastitis in cows in Italy [43, 90]. The CC1 strains may carry different SCCmec types, such as SCCmec IV and type 5(5C2).

Other Lineages

On several occasions, human-associated MRSA was found in livestock. A peculiar situation was found in Belgium, where ST239 was found in pigs, bovines, and poultry [2•, 22, 26]. ST239 is a typical human-associated MRSA found in livestock, at low prevalence, only in Belgium. The reason this sequence type was found in livestock only in Belgium is not known, and it would be interesting to follow its evolution. Moreover, the PVL-positive CA-MRSA ST80/t044 SCCmec IV European clone was detected recently among pigs in Belgium [2•].

Similarly, strains of ST5 (belonging to CC5) commonly associated with human infections have been isolated from pork and pigs in the USA [9193]. Unlike ST293, the prevalence of this CC frequently is higher than that of CC398. CC5 strains also have been detected in Canada [94]. A striking observation regarding CC5 is that strains of this lineage, especially ST5, have had host jumps to poultry, in which it frequently is implicated in disease [95]. In fact, broiler chicken and turkey ST5 isolates with avian-niche-specific genes of the φAvβ prophage have been described [4••, 33••]. The significance of ST5 in pigs and on pork remains unclear; however, besides human contamination, which is unlikely despite the high prevalence in some studies, it also may be a new emerging LA-MRSA clone in the USA, as it was shown recently that ST5 is one of the three most frequent MSSA clones found in pigs in Minnesota [73]. Further studies on ST5 are warranted to determine its origin and relationship to human or poultry strains. The evolution of these strains also should be followed closely given their close relationship to highly pathogenic and hospital (health care)-acquired (HA) human MRSA strains.

Occasionally, sequence types are found that are associated not only with humans. Sequence types specifically associated with a certain livestock host are being reported more frequently, suggesting the spread of SCCmec among other animal S. aureus clones. MRSA CC30 was found recently in pigs from Denmark [89], and isolates from several CCs (CC8, CC9, CC20, CC30, CC45, CC479, CC522, and CC705) have been described among bovine and pig isolates [22, 29•].

SCC mec Type XI, mecC-carrying MRSA From Animals

SCCmec type XI, containing a new mecC gene (formerly named mecA LGA251), was first described from a strain originating from mastitis in cows and from humans in the UK and Denmark [96]. It was discovered because it was negative on mecA PCR but phenotypically resistant. Although this SCCmec type is associated mainly with CC130, it also has been found in CC1943 and CC425 as well as in many other CCs, including CC599 and CC59 [97, 98, 99].

Subsequently, other laboratories started testing for mecC on their mecA-negative strains showing phenotypic resistance. All these studies indicate only a low prevalence; however, these mecC-positive strains appear to be widespread, at least in Europe, and seem to be present in different animal species, including humans, as well as in the environment [99, 100]. The livestock animal species involved are mainly dairy cattle, and these strains have not been recovered from pigs or poultry so far. Other animals involved include sea mammals, pet animals, wildlife (birds and mammals), and zoo animals [9799, 101106]. Of note, the ST130 strains carrying SCCmec type XI are likely to be zoonotic and to cause infections in animals [98, 107]. Typically, they carry a diverse array of virulence factors, such as hemolysins, immune evasion factors, enterotoxins, and/or TSST-1 [98].

To our knowledge, mecC has never been found outside Europe, although that may be because few studies have looked for it. Some studies in the USA have looked for but failed to detect it (Tara Smith, personal communication). Nevertheless, there are indications that the mecC strains have a limited geographic spread, as was demonstrated for the strains isolated in France [107].

The SCCmec type XI is divergent in the mec region (it carries a β-lactamase blaZ gene together with the mec operon genes) and in other parts of the cassette compared to other SCCmec types [96]. This divergence indicates that it had an independent evolution, although it is not yet known how it evolved. It also indicates that although the earliest strain found was from 1975, this type may have been circulating for an even longer period [97, 98]. This appears similar to what is observed for mecA-carrying SCCmec elements in coagulase-negative staphylococci; however, for mecC of course fewer strains are available to date, and the diversity is still difficult to assess. The gene mecC has been detected in Staphylococcus xylosus, S. sciuri, and Staphylococcus stepanovicii [108110]. The mecC allotypes in the S. sciuri and S. xylosus strains are different and are integrated in different SCCmec structures, demonstrating the potential diversity in SCCmec mecC-carrying elements in staphylococci other than S. aureus. However, to our knowledge, no real surveillance has been performed on mecC in staphylococci other than S. aureus. In addition, the prevalence of coagulase-negative strains appears low, although this observation is based merely on the fact that for most strains tested to date (of which there are few) mecA rather than mecC was present [seeMethicillin Resistance in Staphylococci Other Than S. aureus (MRNaS) From Animals and the Possibility of Their Creating New LA-MRSA Clones” section]. It should be noted also that the S. sciuri strain carries both a mecA and a mecC gene, and likewise it may be that more mecA-positive strains carry an additional mecC. Further studies are necessary to determine the role of mecC-carrying elements in methicillin resistance in staphylococci other than S. aureus.

Evolution of LA-MRSA in Europe

LA-MRSA was first detected in the Netherlands [1] and France [111] around the middle of the first decade of the twenty-first century. Before that, reports of methicillin resistance in S. aureus appeared occasionally, the first one on a case of MRSA of human origin isolated from milking cows [112]. However, most of these reports lacked typing data and were based only on phenotypic detection; therefore, they should be interpreted with care. The first confirmed case of LA-MRSA in 2004 in the Netherlands was detected by accident, in a young girl who was colonized by MRSA and could not be decolonized [1, 113]. Upon further investigation into the causes, it was discovered that the source of this MRSA was the pigs on the farm where the girl and her family lived. After this lineage was found to be highly prevalent, many European countries became concerned regarding their own situation. Neighboring countries with similar animal-rearing practices began their own surveillance and found a high prevalence of MRSA in their pigs also [24, 114]. These findings ultimately led to a multinational European surveillance system to detect MRSA in pigs. Unfortunately, the sampling used by the system consisted of dust samples, which later were shown to have a low sensitivity. Moreover, the isolation method used (double-selective enrichment) was shown to be suboptimal in low-prevalence populations, such as poultry [26]. These limitations resulted in a lower estimated prevalence, which also is exemplified by the lower prevalence in Belgium during that study. Whereas the first surveillance showed a prevalence of approximately 60 % [20], the EFSA study identified a prevalence of only about 40 % [67], and a subsequent surveillance found a prevalence greater than 60 % [2•]. These results demonstrate that uniform sampling and isolation are of the utmost importance in comparing data.

Prevalence rates among European countries differ substantially. In some countries, no MRSA was found, whereas in others, the prevalence was high and there was a whole in-between group [68]. As stated earlier, the sensitivity of this study was quite low, and the research did not allow sampling from, for example, pigs raised outdoors, which is still done frequently in some countries. Although dust sampling from outdoor-reared pigs is rather irrelevant, the reasons for this high variability remain quite obscure; there certainly is an indication that international trade increased the spread of LA-MRSA CC398.

The CC398 strains initially were named NT-MRSA, because their genomic DNA could not be digested with the SmaI endonuclease, the enzyme used in the PFGE method for S. aureus. This was a result of the action of C5-cytosine methyltransferase, which modifies the consensus sequence recognized by SmaI [115, 116]. Although several enzymes were used as an alternative [117], their profiles were not comparable with those generated by SmaI in non-CC398 isolates. To overcome this problem, the use of Cfr9I, a neoschizomer (an enzyme that cuts within the same recognition sequence) of SmaI, was proposed [116], and this enzyme was used successfully for PFGE typing of CC398 isolates [59]. Although the use of Cfr9I allowed direct comparison with SmaI–PFGE profiles, differentiation of LA-MRSA CC398 was based mainly on SCCmec and spa typing. Initially, CC398 SCCmec was thought to be type III; however, later it was proven that it was mainly types IV and V, and the isolates typed as SCCmec III corresponded to type V [58, 59]. To date, little variation has been seen in the prevalence of CC398 strains; however, with increased use of zinc oxide in some European countries, SCCmec type V (5C2&5) may increase. Indeed, after the discovery of the zinc oxide resistance gene (czrC) in MRSA CC398 [118] and its location on SCCmec type V [119121], a randomized controlled trial and an epidemiologic study showed that zinc oxide selects for MRSA CC398 SCCmec type V in vivo [122, 124]. The possible co-selection of MRSA through zinc oxide application in pigs is supported further by pig experiments showing that treatment with zinc oxide alone and in combination with tetracycline influences the MRSA load in the nasal cavity [124]. Besides SCCmec types IV and V, other types have been described rarely, and these are mainly NT SCCmec types [2•, 22, 29•]. However, SCCmec also undergoes an evolution, as exemplified by the fact that there are MSSA CC398 strains with an SCC remnant V(5C2&5) from which the mec gene complex has been deleted. Strikingly, this element still carries the zinc and tetracycline resistance genes [29•].

The history of MRSA CC398 is young, with scientific investigation starting a little more than 10 years ago. However, it must have been circulating in pigs earlier, given its high prevalence in some countries, although it is difficult to estimate how long it has been circulating. In their recent study, Espinosa-Gongora et al. [71] found that ST398 was absent in collections of pig isolates recovered between 1973 and 2003. The authors suggested that CC398 was either absent or present at low frequencies in pigs in the past and confirmed the current theory that S. aureus ST398 did not originate in pigs. The period during which CC398 has been circulating might be rather short given the high transmission ratios [21] and the intense trade of pigs throughout Europe [36, 67, 68]. Thus, it is supposed that the evolution of this clone in animals began quite recently. Indeed, there are some indications that this population is in an early stage of evolution because the diversity of spa types found in specific geographic regions is still increasing [2•]. Moreover, recent papers [29•] also indicate other lineages arising within the pig population, highlighting the continuous evolution of MRSA dynamics in this species and the need for continuous surveillance so that if new and perhaps more dangerous clones arise, early intervention strategies may be executed. Because the main route by which these new MRSA types spread is trade [68], it is clear that new trade policies must be developed to prevent the spread. For countries in which MRSA is absent, it is especially important to import only MRSA-free pigs. However, there currently is no legal basis for preventing the entry of MRSA pigs or other animals so that these countries can protect their livestock from becoming colonized with MRSA.

At the moment, it is difficult to predict how MRSA will evolve. We know that in countries where it is highly prevalent, the prevalence will not decrease. Positive farms will remain positive, and there is no indication they will become negative [2•]. In some countries, negative farms will become difficult to find; moreover, the problem will affect not only pigs, but bovines as well [22, 23••].

In bovines, controlling cases of S. aureus mastitis, as well as those caused by MRSA, has proven profitable, although some pitfalls must be taken into account. First, eliminating S. aureus mastitis is not easy; it involves the culling of animals testing positive. Second, LA-MRSA also is carried in the nose [22], which may complicate its elimination. Unfortunately, the transmission ratio of LA-MRSA in adult cattle is unknown; therefore, it is impossible to estimate the success of eradication if other animals, colonized only in the nose, need to be culled. The estimated prevalence of nose carriage is approximately 10 %, and it is unknown whether these animals also carry the bacterium in their udders [22, 23••].

Evolution of LA-MRSA in North America

Studies of LA-MRSA in North America are several years behind those in Europe. They also have been hampered by the increased difficulty of obtaining on-farm samples because of reduced government regulation of farming compared to many European countries. Nevertheless, several studies have been carried out in cooperation with farmers and farming groups to investigate the epidemiology of LA-MRSA in North America. To date, however, no studies examining this issue have been published in Mexico, and those from the USA and Canada are limited and represent the findings from only a handful of states and provinces.

Although ST398 is identified commonly in pigs and farming environments in North America [73, 9294, 125133], there appears to be a greater diversity of molecular types found on North American farms compared with those in Europe, where ST398 remains the dominant or sole strain of MRSA identified. One study in Michigan found no ST398 present in the pigs sampled [134], whereas the bulk of studies have found a mix of “human” types (such as ST8 and ST5) in conjunction with ST398.

Typing of SCCmec has been carried out in only a few North American studies. Smith et al. [127] typed all human strains and 15 representative swine isolates, all ST398; all were found to be type V. Molla et al. [93] tested all MRSA isolates (n = 99), among which they identified type V (16 %), type II (7 %), and type IV (5.1 %); they reported 4 % as NT. The authors also noted that “although the majority of the MRSA isolates (67 %) had identifiable ccr gene and mec gene complexes, the combinations we found did not match the currently reported types, suggesting that, like in Europe, a new SCCmec type(s) might be circulating in the porcine isolates.” Like the diversity of spa types and STs found in North American pigs, that of SCCmec types also does not lend itself easily to comparison elsewhere.

Evolution of LA-MRSA in Asia

The situation in Asia is very different from the one in Europe and USA. In most Asian countries, CC9 predominates among livestock, in contrast to the widespread CC398-MRSA in Europe and North America [17]. MRSA ST9 and variants have been isolated from pigs in China, Hong Kong, Malaysia, Thailand, Japan, and South Korea [17], but other MRSA lineages, such as ST22, ST221, and ST398, occasionally have been reported among pigs from Asian countries [17].

In Asia, the overall carriage rate of MRSA in pigs is generally low. The prevalence of CC9, the most prevalent MRSA lineage among pigs, varies widely: 1.4 % in Malaysia [135], 10 % in Thailand [136], 4 to 13.9 % in Taiwan [137, 138], 11.4 to 14.7 % in China [139, 140], and 21.3 % in Hong Kong [141]. However, a recent study found a high nasal rate (40 %) of MRSA CC9 among pigs in Thailand [142]. MRSA CC9 isolates also have been detected in dust samples from pig farms in China [143] and at a low frequency in chickens and meat (chicken and beef) samples from Hong Kong [141, 144]. Similarly, MRSA CC9 among pig farmers in Asian countries also appears low (5–19 %) [135, 138, 139].

Although most LA-MRSA CC9 isolates in Asia are typed as ST9, single-locus variants (such as ST1376) also have been found [143]. LA-MRSA ST9 isolates carry different types of SCCmec depending on the country: types IV and V in Taiwan [78]; types III and IVb in China [139, 140]; type IV, IVb, or V in Hong Kong [141, 144, 145]; type V in Malaysia [135]; and type IX in Thailand [142, 146]. LA-MRSA CC9 isolates with NT SCCmec cassettes also have been described in Taiwan [78, 137, 138], and recently a novel SCCmec type with ccrAB type 1 and mec class C was found in ST9-t337 from Thailand [136]. Moreover, distribution of the different spa types also is country related: t899 predominates in China [139, 140] and Hong Hong [141, 144], t4358 in Malaysia [135], and t337 in Thailand [76, 136]; however, other related spa types (such as t2922) have been found in LA-MRSA CC9 [140].

A recent study proved that the Taiwan clone of LA-MRSA ST9 and human clinical ST9-MRSA belong to a novel staphylocoagulase (SC) XIc subtype [76]. In this study, ST9 MRSA isolates of human and swine origin showed a highly homogeneous virulence genotype and genomic profiles. The authors suggested the existence of a recent common ancestor and a cross-species transmission of the emerging ST9-SCXIc MRSA between swine and humans [76].

LA-MRSA CC398, including ST398-t034 and ST541-t034, initially were found at a low carriage rate (2.6 %) in commercial pigs from South Korea [16]. However, these isolates may have an American or European origin, as breeding pigs were imported from the USA, Canada, and Denmark [16]. In this study, few isolates (prevalence of 0.6 %) were typed as ST72-SCCmec IVa PVL-negative, which corresponded to the CA-MRSA lineage more prevalent in that country [16]. MSSA CC398 isolates also have been reported occasionally in pigs from Japan [72], as well as at a high carriage rate (16.8 %) in pigs from China [140]. In a research hospital in Singapore, MRSA ST398 isolates also were found in experimental pigs obtained from Indonesia [147].

Regarding other lineages, LA-MRSA ST221-t002 was isolated from a swine nasal sample (0.9 %) in Japan [148], and an ST22-SCCmec IV isolate also was isolated in the experimental pigs of the Singapore research hospital [147].

LA-MRSA in Other Parts of the World

Little is known about the prevalence of LA-MRSA in developing countries. Although few studies have been performed on the epidemiology of LA-MRSA in Africa [18, 149152], several lineages have been detected, such as the human-associated ST5-SCCmec IV and ST88-SCCmec IV in pigs from Senegal [151] and ST153-SCCmec NT from healthy sheep in Tunisia [152]. Moreover, one veterinarian from Tunisia carried an ST80-SCCmec IVc isolate [153], but interestingly, human-associated S. aureus lineages have been described in chimpanzees, possibly as the result of humanosis [18].

Methicillin Resistance in Staphylococci Other Than S. aureus (MRNaS) From Animals and the Possibility of Their Creating New LA-MRSA Clones

To date, methicillin resistance has been detected in most staphylococcal species, demonstrating that SCCmec perhaps is more mobile than suspected, especially considering that most S. aureus (the most-studied species) clones are not very competent in taking up foreign DNA. It has been shown that specific restriction modification systems in S. aureus are capable of blocking horizontal gene transfer [154]. These restriction modification systems are lineage specific [155], which is exemplified by the fact that frequently in ecosystems, only a few methicillin-resistant clones are circulating whereas the diversity of the methicillin-susceptible clones is much greater. A perfect example of this is the limited number of LA-MRSA clones compared with MSSA clones infecting animals and the introduction of methicillin resistance in animal-associated S. aureus, which occurred only recently, as discussed earlier.

Clearly, the SCCmec types found in MRNaS are similar to those in S. aureus, although the variability in MRNaS appears much greater, including the presence of NT cassettes. It should be noted that few data exist for most of the MRNAS, making it difficult to assess the variability of SCCmec. Studies also have been performed in which the SCCmec cassettes have been characterized further [59, 10••, 11, 46, 156, 157].

However, these analyses are not detailed enough to demonstrate the transfer of SCCmec. As shown [158], there is much more variation in the sequences, and ideally the SCCmec types should be subdivided based on differences in sequences. This task has become feasible with new-generation sequencing; therefore, it no longer will be a great challenge to develop a more detailed subtyping scheme of SCCmec types to enable researchers to follow their movements, plasticity, and epidemiology.

Clearly, the prevalence of the different SCCmec types in MRNaS also differs from that of S. aureus. This difference simply may be a result of the possibility that—based on epidemiologic data, as presented earlier—staphylococci other than S. aureus might acquire SCCmec more easily; however, this needs further confirmation.


It is clear that the story of LA-MRSA is not over. New challenges may arise with the diversification of LA-MRSA, through which new spa types might arise, and new sequence types might acquire methicillin resistance from the large reservoir that exists in other staphylococcal species, although the latter requires more definitive characterization.

The prevalence of LA-MRSA is low in some countries and high in others. Some countries, such as Norway, are trying to become negative for LA-MRSA; however, this appears very challenging [159]. Based on our current knowledge of the epidemiology of methicillin resistance in staphylococci, it is difficult to forecast what the future holds. Certainly, LA-MRSA is a recent event, and it requires more research on methicillin resistance in all staphylococcal species in order to estimate its risk for both animal and human health.